These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2299739)
1. Photodynamic therapy for localised prostatic cancer: light penetration in the human prostate gland. Pantelides ML; Whitehurst C; Moore JV; King TA; Blacklock NJ J Urol; 1990 Feb; 143(2):398-401. PubMed ID: 2299739 [TBL] [Abstract][Full Text] [Related]
2. Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy. Zhu TC; Dimofte A; Finlay JC; Stripp D; Busch T; Miles J; Whittington R; Malkowicz SB; Tochner Z; Glatstein E; Hahn SM Photochem Photobiol; 2005; 81(1):96-105. PubMed ID: 15535736 [TBL] [Abstract][Full Text] [Related]
3. In situ comparison of 665 nm and 633 nm wavelength light penetration in the human prostate gland. Lee LK; Whitehurst C; Pantelides ML; Moore JV Photochem Photobiol; 1995 Nov; 62(5):882-6. PubMed ID: 8570727 [TBL] [Abstract][Full Text] [Related]
4. In vivo laser light distribution in human prostatic carcinoma. Whitehurst C; Pantelides ML; Moore JV; Brooman PJ; Blacklock NJ J Urol; 1994 May; 151(5):1411-5. PubMed ID: 8158797 [TBL] [Abstract][Full Text] [Related]
5. Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy. Jankun J; Keck RW; Skrzypczak-Jankun E; Lilge L; Selman SH BJU Int; 2005 Jun; 95(9):1237-44. PubMed ID: 15892808 [TBL] [Abstract][Full Text] [Related]
6. An interstitial light assembly for photodynamic therapy in prostatic carcinoma. Lee LK; Whitehurst C; Pantelides ML; Moore JV BJU Int; 1999 Nov; 84(7):821-6. PubMed ID: 10532979 [TBL] [Abstract][Full Text] [Related]
7. Optimization of multifiber light delivery for the photodynamic therapy of localized prostate cancer. Whitehurst C; Pantelides ML; Moore JV; Blacklock NJ Photochem Photobiol; 1993 Oct; 58(4):589-93. PubMed ID: 8248336 [TBL] [Abstract][Full Text] [Related]
8. TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer. Azzouzi AR; Barret E; Moore CM; Villers A; Allen C; Scherz A; Muir G; de Wildt M; Barber NJ; Lebdai S; Emberton M BJU Int; 2013 Oct; 112(6):766-74. PubMed ID: 24028764 [TBL] [Abstract][Full Text] [Related]
9. Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers. Chen Q; Huang Z; Luck D; Beckers J; Brun PH; Wilson BC; Scherz A; Salomon Y; Hetzel FW Photochem Photobiol; 2002 Oct; 76(4):438-45. PubMed ID: 12405153 [TBL] [Abstract][Full Text] [Related]
10. Light penetration in the human prostate: a whole prostate clinical study at 763 nm. Moore CM; Mosse CA; Allen C; Payne H; Emberton M; Bown SG J Biomed Opt; 2011; 16(1):015003. PubMed ID: 21280905 [TBL] [Abstract][Full Text] [Related]
11. Monte Carlo modelling of angular radiance in tissue phantoms and human prostate: PDT light dosimetry. Barajas O; Ballangrud AM; Miller GG; Moore RB; Tulip J Phys Med Biol; 1997 Sep; 42(9):1675-87. PubMed ID: 9308075 [TBL] [Abstract][Full Text] [Related]
12. Laser dosimetry studies in the prostate. Chen Q; Hetzel FW J Clin Laser Med Surg; 1998 Feb; 16(1):9-12. PubMed ID: 9728124 [TBL] [Abstract][Full Text] [Related]
13. Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy. Chen Q; Wilson BC; Shetty SD; Patterson MS; Cerny JC; Hetzel FW Radiat Res; 1997 Jan; 147(1):86-91. PubMed ID: 8989374 [TBL] [Abstract][Full Text] [Related]
14. Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin. Chang SC; Buonaccorsi G; MacRobert A; Bown SG Int J Cancer; 1996 Aug; 67(4):555-62. PubMed ID: 8759616 [TBL] [Abstract][Full Text] [Related]
15. Towards accurate in vivo spectroscopy of the human prostate. Svensson T; Alerstam E; Einarsdóttír M; Svanberg K; Andersson-Engels S J Biophotonics; 2008 Aug; 1(3):200-3. PubMed ID: 19412969 [TBL] [Abstract][Full Text] [Related]
16. Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. Zhu TC; Finlay JC; Hahn SM J Photochem Photobiol B; 2005 Jun; 79(3):231-41. PubMed ID: 15896650 [TBL] [Abstract][Full Text] [Related]
17. Analysis of tissue optical coefficients using an approximate equation valid for comparable absorption and scattering. Arnfield MR; Mathew RP; Tulip J; McPhee MS Phys Med Biol; 1992 Jun; 37(6):1219-30. PubMed ID: 1626022 [TBL] [Abstract][Full Text] [Related]
18. Spatial distribution of liposome encapsulated tin etiopurpurin dichloride (SnET2) in the canine prostate: implications for computer simulation of photodynamic therapy. Aniola J; Selman SH; Lilge L; Keck R; Jankun J Int J Mol Med; 2003 Mar; 11(3):287-91. PubMed ID: 12579328 [TBL] [Abstract][Full Text] [Related]
19. Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer. Davidson SR; Weersink RA; Haider MA; Gertner MR; Bogaards A; Giewercer D; Scherz A; Sherar MD; Elhilali M; Chin JL; Trachtenberg J; Wilson BC Phys Med Biol; 2009 Apr; 54(8):2293-313. PubMed ID: 19305043 [TBL] [Abstract][Full Text] [Related]
20. Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate. Johansson A; Axelsson J; Andersson-Engels S; Swartling J Med Phys; 2007 Nov; 34(11):4309-21. PubMed ID: 18072496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]